These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6517002)

  • 1. [Amikacin concentration in the severely obstructed urinary tract].
    Yamasaki Y; Arima K; Ogawa H; Hori N; Kinoshita N; Katoh M; Tochigi H; Tada S
    Hinyokika Kiyo; 1984 Aug; 30(8):1127-34. PubMed ID: 6517002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood level of amikacin after drip intravenous infusion (author's transl)].
    Sawae Y; Takii M
    Jpn J Antibiot; 1980 Apr; 33(4):539-48. PubMed ID: 7411857
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD; Ling GV; Chatfield RC
    Am J Vet Res; 1985 Aug; 46(8):1793-6. PubMed ID: 4037511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dose in the urinary excretion of amikacin.
    Lanao JM; Pedraz JL; Navarro AS; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):538-42. PubMed ID: 6511129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
    Ling GV; Conzelman GM; Franti CE; Ruby AL
    Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the local use of amikacin].
    Wada S; Nishio S; Kishimoto T; Maekawa M; Yuki K; Sasaki S; Oshima N; Hayahara N; Nishijima T; Funai K
    Hinyokika Kiyo; 1985 May; 31(5):907-13. PubMed ID: 4050636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin pharmacokinetics in the therapy of childhood urinary tract infection.
    Khan AJ; Evans HE; Jhaveri R; Chang CT; Hochstein L
    Pediatrics; 1976 Dec; 58(6):873-6. PubMed ID: 995517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amikacin in urinary tract infections with so-called problem pathogens].
    Hofstetter A; Staehler G
    Fortschr Med; 1976 Aug; 94(24):1305-8. PubMed ID: 786834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental and clinical studies of intravenous infusion of amikacin in acute respiratory tract infections].
    Ito T
    Jpn J Antibiot; 1982 Aug; 35(8):2111-25. PubMed ID: 7154253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of infusion of amino acids on the renal elimination of amikacin].
    Aubertin J; Lacut JY; Quentin C; Lafontaine N; Aparicio M; Ragnaud JM; Loste P
    Nouv Presse Med; 1979 Oct; 8(42):3498-500. PubMed ID: 537904
    [No Abstract]   [Full Text] [Related]  

  • 11. [Penetration of amikacin into the anterior chamber of the human eye].
    Barrera V; Sinues B; Martinez P; Buatas A; Pinero A
    J Fr Ophtalmol; 1984; 7(8-9):539-43. PubMed ID: 6520334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetics of cefotaxime in healthy subjects (author's transl)].
    Acar JF; Guibert J; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):559-63. PubMed ID: 6259593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Absorption, excretion and distribution of amikacin following intravenous drip infusion. Intravenous drip infusion, one shot intravenous injection and intramuscular administration of amikacin in dogs, rabbits and rats].
    Matsumoto H; Ochiai K; Nakajima A; Matsuzaki M
    Jpn J Antibiot; 1982 Aug; 35(8):2034-46. PubMed ID: 7154249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience with intravenous drip infusion of amikacin in urological field (author's transl)].
    Murahashi I; Toyoda A; Takasaki E
    Jpn J Antibiot; 1981 Feb; 34(2):133-9. PubMed ID: 7253190
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)].
    Hotta T; Hirabayashi N; Shimizu K; Utsumi M; Katoh T; Maeda H; Hirano A; Ohnishi K; Murate T; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1457-64. PubMed ID: 7334580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serial measurement of serum levels of amikacin. Value in therapy].
    Granthil C; Savin B; Charrel CT; Martin C; Gouin F; François G
    Ann Anesthesiol Fr; 1981; 22(2):207-11. PubMed ID: 6115609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patients.
    Danhauer FJ; Fortner CL; Schimpff SC; deJongh CA; Wesley MN; Wiernik PH
    Clin Pharm; 1982; 1(6):539-43. PubMed ID: 7185540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on effect of local administration of amikacin for complicated cystitis accompanied by residual urine].
    Ueda K
    Hinyokika Kiyo; 1984 May; 30(5):715-8. PubMed ID: 6206706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with intravenous drip infusion of amikacin (author's transl)].
    Ishii T; Kishimoto S
    Jpn J Antibiot; 1981 Jul; 34(7):1063-70. PubMed ID: 7321184
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacology of amikacin and kanamycin.
    Kirby WM; Clarke JT; Libke RD; Regamey C
    J Infect Dis; 1976 Nov; 134 SUPPL():S312-5. PubMed ID: 993624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.